Lilach Lerman

Dr. Lilach Lerman

Division of Nephrology and Hypertension, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2022 in Nature Reviews Nephrology
Verified
Journal Article
Closed access
PDF file
WHWeijun Huang
Weijun Huang
LHLaTonya J. Hickson
LaTonya J. Hickson
Alfonso EirinAlfonso Eirin
Alfonso Eirin
JKJames L. Kirkland
James L. Kirkland
LLLilach Lerman
Lilach Lerman

1 March 2015 in The American Journal of Medicine
Verified
Journal Article
Closed access
RWR. Jay Widmer
R. Jay Widmer
AFAndreas J. Flammer
Andreas J. Flammer
LLLilach Lerman
Lilach Lerman
ALAmir Lerman
Amir Lerman

1 July 2017 in Kidney International
Verified
Journal Article
Closed access
AEAlfonso Eirin
Alfonso Eirin
XZXiang-Yang Zhu
Xiang-Yang Zhu
APAmrutesh S. Puranik
Amrutesh S. Puranik
HTHui Tang
Hui Tang
KMKelly A. McGurren
Kelly A. McGurren
LLLilach Lerman
Lilach Lerman

1 November 2014 in Gene
Verified
Journal Article
Closed access
AEAlfonso Eirin
Alfonso Eirin
SRScott M. Riester
Scott M. Riester
XZXiang-Yang Zhu
Xiang-Yang Zhu
HTHui Tang
Hui Tang
JEJared M. Evans
Jared M. Evans
LLLilach Lerman
Lilach Lerman

9 April 2012 in Stem Cells
Verified
Journal Article
Closed access
PDF file
AEAlfonso Eirin
Alfonso Eirin
XZXiang‐Yang Zhu
Xiang‐Yang Zhu
JKJames D. Krier
James D. Krier
HTHui Tang
Hui Tang
KJKyra L. Jordan
Kyra L. Jordan
LLLilach Lerman
Lilach Lerman

1 February 2001 in Hypertension
Verified
Journal Article
Open access
PDF file
LLLilach Lerman
Lilach Lerman
KNKarl A. Nath
Karl A. Nath
MRMartin Rodriguez-Porcel
Martin Rodriguez-Porcel
JKJames D. Krier
James D. Krier
RSRobert S. Schwartz
Robert S. Schwartz
JRJ. Carlos Romero
J. Carlos Romero
The pathophysiological mechanisms responsible for maintenance of chronic renovascular hypertension remain undefined. Excess angiotensin II generation may lead to release of reactive oxygen species and increased vasoconstrictor activity. To examine the potential involvement of oxidation-sensitive mechanisms in the pathophysiology of renovascular hypertension, blood samples were collected and renal blood flow measured with electron-beam computed tomography in pigs 5 and 10 weeks after induction of unilateral renal artery stenosis (n=7) or sham operation (n=7). Five weeks after procedure, plasma renin activity and mean arterial pressure were elevated in hypertensive pigs. Levels of prostaglandin F2α (PGF 2α )–isoprostanes, vasoconstrictors and markers of oxidative stress, also were significantly increased (157±21 versus 99±16 pg/mL; P <0.05) and correlated with both plasma renin activity ( r =0.83) and arterial pressure ( r =0.82). By 10 weeks, plasma renin activity returned to baseline but arterial pressure remained elevated (144±10 versus 115±5 mm Hg; P <0.05). Isoprostane levels remained high and still correlated directly with the increase in arterial pressure ( r =0.7) but not with plasma renin activity. Stenotic kidney blood flow was decreased at both studies. In shock-frozen cortical tissue, ex vivo endogenous intracellular radical scavengers were significantly decreased in both kidneys. The present study demonstrates, for the first time, that in early renovascular hypertension, an increase in plasma renin activity and arterial pressure is associated with increased systemic oxidative stress. When plasma renin activity later declines, PGF 2α -isoprostanes remain elevated, possibly due to local activation or slow responses to angiotensin II, and may participate in sustenance of arterial pressure. Moreover, oxidation-sensitive mechanisms may influence ischemic and hypertensive parenchymal renal injury.